Abstract
Aims: Our objective was to investigate the steady‐state pharmacokinetic and pharmacodynamic interaction between the antidepressive herbal medicineStJohn's wort and the antidiabetic drug metformin.Methods: We performed an open cross‐over study in 20 healthy male subjects, who received 1 g of metformin twice daily for 1 week with and without 21 days of preceding and concomitant treatment withStJohn's wort. The pharmacokinetics of metformin was determined, and a 2 h oral glucose tolerance test was performed.Results: StJohn's wort decreased the renal clearance of metformin but did not affect any other metformin pharmacokinetic parameter. The addition ofStJohn's wort decreased the area under the glucose concentration–time curve [702 (95% confidence interval, 643–761)vs. 629 min*mmol/L (95% confidence interval, 568–690),P= 0.003], and this effect was caused by a statistically significant increase in the acute insulin response.Conclusions: StJohn's wort improves glucose tolerance by enhancing insulin secretion independently of insulin sensitivity in healthy male subjects taking metformin.
Funding Information
  • The Psychiatric Research Council of Southern Denmark

This publication has 40 references indexed in Scilit: